Therapeutic Potential of Emodin for Gastrointestinal Cancers

Gastrointestinal (GI) cancers cause one-third of all cancer-related deaths worldwide. Natural compounds are emerging as alternative or adjuvant cancer therapies given their distinct advantage of manipulating multiple pathways to both suppress tumor growth and alleviate cancer comorbidities; however,...

Full description

Bibliographic Details
Main Authors: Sierra J. McDonald BS, Brandon N. VanderVeen PhD, Kandy T. Velazquez PhD, Reilly T. Enos PhD, Ciaran M. Fairman PhD, Thomas D. Cardaci MS, Daping Fan MD/PhD, E. Angela Murphy PhD
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354211067469